COLITIS, ULCERATIVE
Clinical trials for COLITIS, ULCERATIVE explained in plain language.
Never miss a new study
Get alerted when new COLITIS, ULCERATIVE trials appear
Sign up with your email to follow new studies for COLITIS, ULCERATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for inflammatory bowel disease: multiple experimental treatments enter testing
Disease control Not yet recruitingThis study is testing several new potential treatments for adults with moderate to severe ulcerative colitis or Crohn's disease. Participants will be assigned to one of several treatment groups to see if these new options work better than current treatments. The study will last a…
Matched conditions: COLITIS, ULCERATIVE
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 01, 2026 21:26 UTC
-
New hope for kids with severe bowel disease: testing a daily pill
Disease control Not yet recruitingThis study is testing a daily oral medication called etrasimod in children aged 2 to 12 who have moderately to severely active ulcerative colitis, a chronic inflammatory bowel disease. The main goal is to see if the drug is safe, effective at controlling the disease, and how it b…
Matched conditions: COLITIS, ULCERATIVE
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
New hope for ulcerative colitis: experimental drug enters testing
Disease control Not yet recruitingThis study is testing whether an experimental drug called MK-8690 can help adults with moderate-to-severe ulcerative colitis. About 100 participants will receive either the drug or a placebo for 12 weeks to see if it reduces bowel inflammation and symptoms like frequent stools an…
Matched conditions: COLITIS, ULCERATIVE
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Live bacteria treatment tested for bowel disease
Disease control Not yet recruitingThis study aims to confirm if a new treatment called MH002 is effective and safe for people with mild-to-moderate ulcerative colitis (UC) whose symptoms aren't fully controlled by their current medication. MH002 is a 'live biotherapeutic' containing specific bacteria designed to …
Matched conditions: COLITIS, ULCERATIVE
Phase: PHASE2 • Sponsor: MRM Health NV • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
Two-Year Follow-Up study tests gut disease Drug's staying power
Disease control Not yet recruitingThis study aims to learn about the long-term safety and effectiveness of an investigational drug called balinatunfib for adults with Crohn's disease or ulcerative colitis. It will follow about 325 people who have already completed a previous 1-year study with this medication. The…
Matched conditions: COLITIS, ULCERATIVE
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Scientists hunt 'Good Viruses' in gut to fight bowel disease
Knowledge-focused Not yet recruitingThis study aims to understand how viruses in the gut, especially those that attack bacteria, differ between healthy people and those with inflammatory bowel disease (IBD). Researchers will collect stool samples from 30 IBD patients and 10 healthy donors to analyze these viruses a…
Matched conditions: COLITIS, ULCERATIVE
Sponsor: Andreas Munk Petersen • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC